Global Smart Diabetes Management Market Size, Share, Growth, Trends, Company Analysis and Forecast 2020 to 2027

Capter 1. Preface
1.1. Definition and Scope
1.2. Segmentation
1.3. MarketKey Research Objectives
1.4. Market Research Highlights
Capter 2. Assumptions and Research Methodology
Capter 3. Executive Summary: Global Smart Diabetes Management Market
Capter 4. Overview
4.1. Introduction
4.1.1. Products Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Dynamics
4.3.1. Drivers
4.3.1.1. Rise in prevalence of diabetes
4.3.1.2. Increase in awareness about diabetes
4.3.1.3. Favourable reimbursement policies
4.3.1.4. Surge in adoption of connected medical devices
4.3.2. Restraints
4.3.2.1. High cost
4.3.2.2. Patient and provider burden
4.3.2.3. Patient privacy & data security
4.3.3. Opportunities
4.4. Global Market Analysis and Forecast, 2019–2026
5. Market Outlook
5.1. Technological Advancement
5.2. Key Development (Product launch, Approval, Collaboration, Partnership, and Acquisitions)
5.3. Diabetes Prevalence in Key Countries
6. Global Market Analysis and Forecast, By Products
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Market Value Forecast, by Product, 2019–2026
6.3.1. Devices
6.3.1.1. Smart Glucose Meters
6.3.1.2. Continuous Glucose Monitoring Systems
6.3.1.3. Smart Insulin Pens
6.3.1.4. Smart Insulin Pumps
6.3.1.5. Closed Loop Systems
6.3.2. Apps & Software
6.4. Global Market Attractiveness, by Product
7. Global Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
7.3.1. Type 1 Diabetes
7.3.2. Type 2 Diabetes
7.4. Global Smart Diabetes Management Market Attractiveness, by Application
8. Global Smart Diabetes Management Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
8.3.1. Self/Home Healthcare
8.3.2. Hospital/Specialty Diabetes Clinics
8.4. Global Smart Diabetes Management Market Attractiveness, by End-user
9. Global Smart Diabetes Management Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Smart Diabetes Management Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Smart Diabetes Management Market Attractiveness, by Region
10. North America Smart Diabetes Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Smart Diabetes Management Market Value Forecast, by Product, 2019–2026
10.2.1. Devices
10.2.1.1. Smart Glucose Meters
10.2.1.2. Continuous Glucose Monitoring Systems
10.2.1.3. Smart Insulin Pens
10.2.1.4. Smart Insulin Pumps
10.2.1.5. Closed Loop Systems
10.2.2. Apps & Software
10.3. North America Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
10.3.1. Type 1 Diabetes
10.3.2. Type 2 Diabetes
10.4. North America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
10.4.1. Self/Home Healthcare
10.4.2. Hospital/Specialty Diabetes Clinics
10.5. North America Smart Diabetes Management Market Value Forecast, by Country, 2019–2026
10.5.1. U.S.
10.5.2. Canada
10.6. North America Smart Diabetes Management Market Attractiveness Analysis
10.6.1. By Products
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Smart Diabetes Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Smart Diabetes Management Market Value Forecast, by Product, 2019–2026
11.2.1. Devices
11.2.1.1. Smart Glucose Meters
11.2.1.2. Continuous Glucose Monitoring Systems
11.2.1.3. Smart Insulin Pens
11.2.1.4. Smart Insulin Pumps
11.2.1.5. Closed Loop Systems
11.2.2. Apps & Software
11.3. Europe Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.4. Europe Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
11.4.1. Self/Home Healthcare
11.4.2. Hospital/Specialty Diabetes Clinics
11.5. Europe Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Smart Diabetes Management Market Attractiveness Analysis
11.6.1. By Products
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Smart Diabetes Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Smart Diabetes Management Market Value Forecast, by Product, 2019–2026
12.2.1. Devices
12.2.1.1. Smart Glucose Meters
12.2.1.2. Continuous Glucose Monitoring Systems
12.2.1.3. Smart Insulin Pens
12.2.1.4. Smart Insulin Pumps
12.2.1.5. Closed Loop Systems
12.2.2. Apps & Software
12.3. Asia Pacific Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
12.3.1. Type 1 Diabetes
12.3.2. Type 2 Diabetes
12.4. Asia Pacific Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
12.4.1. Self/Home Healthcare
12.4.2. Hospital/Specialty Diabetes Clinics
12.5. Asia Pacific Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Smart Diabetes Management Market Attractiveness Analysis
12.6.1. By Products
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Smart Diabetes Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Smart Diabetes Management Market Value Forecast, by Product, 2019–2026
13.2.1. Devices
13.2.1.1. Smart Glucose Meters
13.2.1.2. Continuous Glucose Monitoring Systems
13.2.1.3. Smart Insulin Pens
13.2.1.4. Smart Insulin Pumps
13.2.1.5. Closed Loop Systems
13.2.2. Apps & Software
13.3. Latin America Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
13.3.1. Type 1 Diabetes
13.3.2. Type 2 Diabetes
13.4. Latin America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
13.4.1. Self/Home Healthcare
13.4.2. Hospital/Specialty Diabetes Clinics
13.5. Latin America Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Smart Diabetes Management Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Smart Diabetes Management Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Product, 2019–2026
14.2.1. Devices
14.2.1.1. Smart Glucose Meters
14.2.1.2. Continuous Glucose Monitoring Systems
14.2.1.3. Smart Insulin Pens
14.2.1.4. Smart Insulin Pumps
14.2.1.5. Closed Loop Systems
14.2.2. Apps & Software
14.3. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Application, 2019–2026
14.3.1. Type 1 Diabetes
14.3.2. Type 2 Diabetes
14.4. Middle East & Africa Smart Diabetes Management Market Value Forecast, by End-user, 2019–2026
14.4.1. Self/Home Healthcare
14.4.2. Hospital/Specialty Diabetes Clinics
14.5. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis
14.6.1. By Products
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2018)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Medtronic
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Dexcom, Inc
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Insulet Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Abbott
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Jiangsu Delfu medical device Co., Ltd
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.7. DIAMESCO CO., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.8. LifeScan, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Glooko, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. GlucoMe
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview